Reply to: neuroprotective effects of dexmedetomidine combined with GDHT for patients undergoing cranial surgery
- PMID: 36479990
- DOI: 10.1097/EJA.0000000000001708
Reply to: neuroprotective effects of dexmedetomidine combined with GDHT for patients undergoing cranial surgery
Comment on
-
Neuroprotective effects of dexmedetomidine combined with goal-directed haemodynamic therapy for patients undergoing cranial surgery.Eur J Anaesthesiol. 2023 Jan 1;40(1):63. doi: 10.1097/EJA.0000000000001714. Eur J Anaesthesiol. 2023. PMID: 36479989 No abstract available.
References
-
- Tian Yi, Xiao X, Zhu X, Ai Rong. Neuroprotective effects of dexmedetomidine combined with goal-directed haemodynamic therapy for patients undergoing cranial surgery. Eur J Anaesthesiol 2023; 40:63.
-
- Chen PH, Tsuang FY, Lee CT, et al. Neuroprotective effects of intraoperative dexmedetomidine versus saline infusion combined with goal-directed haemodynamic therapy for patients undergoing cranial surgery: a randomised controlled trial. Eur J Anaesthesiol 2021; 38:1262–1271.
-
- Wu CY, Lu YF, Wang ML, et al. Effects of dexmedetomidine infusion on inflammatory responses and injury of lung tidal volume changes during one-lung ventilation in thoracoscopic surgery: a randomized controlled trial. Mediators Inflamm 2018; 2018:2575910.
-
- Kadish AH, Buxton AE, Kennedy HL, et al. ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: a report of the ACC/AHA/ACP–ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography) Endorsed by the International Society for Holter and Noninvasive Electrocardiology. 2001; 38:2091--2100. J Am Coll Cardiol 2001; 38:2091–2100.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
